LOX-PP also inhibits radiation-induced activating phosphorylation of ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) to inhibit DNA repair pathways in prostate cancer xenograft growth [24]. Here, CHEK2 is linked to prostate carcinoma.